Showing 20 articles starting at article 1421
< Previous 20 articles Next 20 articles >
Categories: Anthropology: General, Biology: Microbiology
Published Researchers find new pathway for HIV invasion of cell nucleus



A study has identified a new pathway that human immune deficiency virus (HIV) uses to enter the nucleus of a healthy cell, where it can then replicate and go on to invade other cells.
Published Gastrointestinal viruses all but disappeared during COVID -- but surged back two years on



Following the first stay-at-home orders issued in the U.S. to curb the spread of COVID-19, gastrointestinal viruses such as norovirus, rotavirus and adenovirus all but disappeared from California communities, and remained at very low levels for nearly 2 years, according to new research.
Published Synthetic antibiotic could be effective against drug-resistant superbugs



A scientific journey decades in the making has found a new antibiotic strategy to defeat gram-negative bacteria like Salmonella, Pseudomonas and E. coli, the culprits in many urinary tract infections. The synthetic molecule works fast and is durable. It interferes with synthesis of the bacterial outer membrane by jamming an enzyme. When tested against a clinical collection of 285 bacterial strains, including some that were highly resistant to commercial antibiotics, it killed them all.
Published Sugars in breastmilk could help treat infections, prevent preterm births



Breastfeeding has long been used as a method to help keep newborns healthy and protected against a variety of diseases. But certain sugars naturally found in breastmilk could also help prevent infections before a baby arrives. Researchers have found that these sugars can stop a common prenatal infection in human tissues and pregnant mice. This could someday help people avoid preterm births or complications without the need for additional antibiotics.
Published Molnupiravir administered at human effect size-equivalent dose blocks SARS-CoV-2 transmission in ferrets, researchers find



Two oral drugs, molnupiravir and paxlovid (nirmatrelvir/ritonavir), provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission when administered at a human effect size-equivalent dose, according to a new study.
Published Treatments for poxviruses -- including those causing mpox and smallpox -- may already exist in licensed drugs



The drug tecovirimat is currently in use for the treatment of mpox -- the disease caused by monkeypox virus -- that spread worldwide in 2022. Tecovirimat is an anti-poxviral drug, and its use is driving the emergence of drug-resistant variants of the monkeypox virus. Scientists have identified how monkeypox virus exploits a cellular protein to evade host defenses, allowing it to replicate and spread better. Existing drugs -- developed to treat other viral infections -- also target this cellular protein. When tested against a range of poxviruses, including monkeypox, these drugs were found to have antiviral effects in all cases.
Published Ancient DNA reveals an early African origin of Cattle in the Americas



Using ancient DNA, researchers have determined cattle were imported from Africa to the Americas much earlier in the process of European colonization than documented. The first records of African cattle in the Americas date back to the 1800s, leading some historians to conclude that early colonists relied entirely on a small stock of European cattle initially shipped to the Caribbean Islands. DNA from archaeological specimens pushes the introduction of African cattle back by more than 100 years.
Published Remission from HIV-1 infection: Discovery of broadly neutralizing antibodies that contribute to virus control



Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms enabling this post-treatment control have not been fully elucidated. Scientists have now investigated and revealed how neutralizing antibodies, including those described as broadly neutralizing, contribute to virus control. A clinical trial involving the use of broadly neutralizing antibodies should begin in France before the end of 2023.
Published Potential novel breakthrough treatment for fungal infections



Fungal infections are killing thousands of Americans each year, some with a morbidity rate of nearly 80%. To make matters worse, only a handful of antifungal treatments are available, and even those are becoming less effective as fungi become more resistant. However, researchers recently published findings indicating that a novel breakthrough treatment may have been discovered.
Published How the Epstein-Barr virus transforms B cells



Epstein-Barr virus (EBV) infection is known to convert resting B lymphocytes into immortal cells that continuously multiply, leading to posttransplant lymphoproliferative disorder (PTLD). Researchers have now uncovered the molecular mechanisms of this growth transformation, demonstrating the crucial role of the cancer-related gene IMPDH2 and nucleolar enlargement. Additionally, the research revealed strong evidence supporting the efficacy of mycophenolate mofetil, an approved immunosuppressant, in inhibiting PTLD, highlighting its therapeutic significance.
Published Astonishing complexity of bacterial circadian clocks



Bacteria make up more than 10% of all living things but until recently we had little realization that, as in humans, soil bacteria have internal clocks that synchronize their activities with the 24-hour cycles of day and night on Earth. New research shows just how complex and sophisticated these bacterial circadian clocks are, clearing the way for an exciting new phase of study.
Published Parasites of viruses drive superbug evolution



Researchers have discovered a previously unknown mechanism by which bacteria share their genetic material through virus parasites. The insights could help scientists to better understand how bacteria rapidly adapt and evolve, and how they become more virulent and resistant to antibiotics.
Published How the hospital pathogen Acinetobacter baumannii quickly adapts to new environmental conditions



Hospital-acquired infections are often hard to treat because the corresponding pathogens become increasingly resistant against antibiotics. The bacterium Acinetobacter baumannii is particularly feared, and there is great pressure to devise novel therapeutic approaches to combat it. Bioinformaticians have now detected an unexpectedly wide diversity of certain cell appendages in A. baumannii that are associated with pathogenicity. This could lead to treatment strategies that are specifically tailored to a particular pathogen.
Published Influenza shows no seasonality in tropics, posing challenges for health care



In temperate climates, like North America and Europe, flu season starts in the fall, peaks in the winter and ends in the spring. While public health officials have generally assumed that influenza is also seasonal in tropical climates, new research has found little evidence of a repeatable pattern in influenza cases in Vietnam. The findings suggest that influenza is likely unpredictable throughout the tropics, posing substantial challenges for prevention and management of cases for the one-third of the global population living in tropical areas.
Published Researchers discuss the ethical challenges of studying DNA from a 18th--19th century African American community



A population genetics team recently identified the genetic relationship between over 40,000 23andMe users and a population of enslaved and free African Americans that lived in Catoctin Furnace, Maryland between 1776--1850. Over the course of this study, the researchers considered how best to inform descendants and other genetic relatives of their genetic connection to the site.
Published New research casts doubt on role of fungus in driving pancreatic cancer



Four years ago, a report that a common species of fungus might fuel pancreatic cancer offered a promising new view of the deadly disease. But in working to validate the finding, researchers have found no such association.
Published Learning how to control HIV from African genomes



A study on almost four thousand people of African descent has identified a gene that acts as natural defense against HIV by limiting its replication in certain white blood cells. This research paves the way for new treatment strategies and underscores the importance of studying diverse ancestral populations to better address their specific medical needs and global health disparities.
Published Scientists develop gene-editing technology that eliminates EV-A71 RNA viruses



A team of scientists has made an important breakthrough in the fight against RNA viruses that cause human diseases and pandemics.
Published Novel molecules fight viruses by bursting their bubble-like membranes



Antiviral therapies are notoriously difficult to develop, as viruses can quickly mutate to become resistant to drugs. But what if a new generation of antivirals ignores the fast-mutating proteins on the surface of viruses and instead disrupts their protective layers?
Published The key to battling a pathogen hides in its genome



The availability, speed and effectiveness of genomic sequencing increased dramatically during the pandemic, as scientists worldwide rushed to find ways to track and predict the virus's movement and evolution. It also was critical in the development of effective vaccines. Biologists argue that building on this momentum is critical in society's response to future pandemics, but it requires significant collaboration and investment now, before the next pathogen is threatening society.